Atb Cap Markets Comments on Organigram Q3 Earnings

Organigram Holdings Inc. (NASDAQ:OGI) – Equities researchers at Atb Cap Markets issued their Q3 2025 earnings per share estimates for Organigram in a research report issued on Wednesday, December 18th. Atb Cap Markets analyst F. Gomes anticipates that the company will earn ($0.01) per share for the quarter. The consensus estimate for Organigram’s current full-year earnings is ($0.20) per share. Atb Cap Markets also issued estimates for Organigram’s Q4 2025 earnings at ($0.01) EPS.

Organigram Trading Up 6.8 %

OGI opened at $1.56 on Friday. The firm has a 50-day moving average price of $1.61 and a two-hundred day moving average price of $1.67. Organigram has a 1-year low of $1.21 and a 1-year high of $2.91. The stock has a market capitalization of $196.80 million, a PE ratio of -3.71 and a beta of 1.02.

Organigram (NASDAQ:OGI) last posted its earnings results on Wednesday, December 18th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.01). Organigram had a negative net margin of 45.57% and a negative return on equity of 16.76%.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. Tidal Investments LLC lifted its holdings in Organigram by 8.3% during the 3rd quarter. Tidal Investments LLC now owns 1,948,188 shares of the company’s stock valued at $3,526,000 after purchasing an additional 149,171 shares during the last quarter. Toronto Dominion Bank lifted its stake in shares of Organigram by 803.7% during the 3rd quarter. Toronto Dominion Bank now owns 16,727 shares of the company’s stock worth $30,000 after buying an additional 14,876 shares during the last quarter. Renaissance Technologies LLC boosted its holdings in shares of Organigram by 40.8% during the 2nd quarter. Renaissance Technologies LLC now owns 816,948 shares of the company’s stock worth $1,258,000 after buying an additional 236,700 shares during the period. Finally, AdvisorShares Investments LLC grew its stake in Organigram by 11.8% in the 2nd quarter. AdvisorShares Investments LLC now owns 1,000,126 shares of the company’s stock valued at $1,540,000 after buying an additional 105,468 shares during the last quarter. 34.63% of the stock is currently owned by institutional investors.

Organigram Company Profile

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.